JP7387951B2 - 皮膚外用剤 - Google Patents
皮膚外用剤 Download PDFInfo
- Publication number
- JP7387951B2 JP7387951B2 JP2022019778A JP2022019778A JP7387951B2 JP 7387951 B2 JP7387951 B2 JP 7387951B2 JP 2022019778 A JP2022019778 A JP 2022019778A JP 2022019778 A JP2022019778 A JP 2022019778A JP 7387951 B2 JP7387951 B2 JP 7387951B2
- Authority
- JP
- Japan
- Prior art keywords
- tulip
- extract
- nicotinamide mononucleotide
- external preparation
- sod
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims description 24
- 241000722921 Tulipa gesneriana Species 0.000 claims description 54
- 239000000284 extract Substances 0.000 claims description 47
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 17
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 16
- 238000000605 extraction Methods 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 240000005924 Stenocarpus sinuatus Species 0.000 claims description 9
- 229940058015 1,3-butylene glycol Drugs 0.000 claims description 8
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 5
- DAYLJWODMCOQEW-TURQNECASA-O NMN(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(O)=O)O2)O)=C1 DAYLJWODMCOQEW-TURQNECASA-O 0.000 claims 2
- DAYLJWODMCOQEW-TURQNECASA-N NMN zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)([O-])=O)O2)O)=C1 DAYLJWODMCOQEW-TURQNECASA-N 0.000 description 33
- 230000000694 effects Effects 0.000 description 29
- 239000000203 mixture Substances 0.000 description 14
- 230000003078 antioxidant effect Effects 0.000 description 13
- 239000000047 product Substances 0.000 description 12
- 238000009472 formulation Methods 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- -1 pH adjusters Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 description 4
- 108010012715 Superoxide dismutase Proteins 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000722923 Tulipa Species 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000012224 working solution Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 229940123973 Oxygen scavenger Drugs 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000001256 steam distillation Methods 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 101000582320 Homo sapiens Neurogenic differentiation factor 6 Proteins 0.000 description 1
- 125000003376 L-ribosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@@H](O1)CO)* 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- JLEBZPBDRKPWTD-TURQNECASA-O N-ribosylnicotinamide Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)=C1 JLEBZPBDRKPWTD-TURQNECASA-O 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 1
- 102100030589 Neurogenic differentiation factor 6 Human genes 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 238000010632 SOD assay Methods 0.000 description 1
- 208000013200 Stress disease Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- ZYPMNZKYVVSXOJ-FRRDWIJNSA-N [(2s,3s,4s)-2,3,4-triacetyloxy-5-oxopentyl] acetate Chemical compound CC(=O)OC[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)C=O ZYPMNZKYVVSXOJ-FRRDWIJNSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- GANYMSDHMBJFIL-UHFFFAOYSA-N acetonitrile;ethoxyethane Chemical compound CC#N.CCOCC GANYMSDHMBJFIL-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000013024 dilution buffer Substances 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000015122 lemonade Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000020956 nicotinamide riboside Nutrition 0.000 description 1
- 239000011618 nicotinamide riboside Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000000865 phosphorylative effect Effects 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 125000000548 ribosyl group Chemical group C1([C@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- ISDBYDBAKGWSCA-UHFFFAOYSA-N trimethoxy phosphate Chemical compound COOP(=O)(OOC)OOC ISDBYDBAKGWSCA-UHFFFAOYSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Description
黄小町品種のチューリップ花部30g(新鮮重)を液体窒素中においてハンマーで粉砕し、2.4倍重量の精製水を添加し、50重量%1,3-ブチレングリコール水溶液を72mL添加し、常温にて1週間静置した後、濾過し、濾液を再度常温で1週間静置後、さらに遠心及び濾過を行いチューリップエキスとした。
[製造例2]直接水蒸気蒸留
黄小町品種のチューリップ花部30g(新鮮重)を液体窒素中においてハンマーで粉砕し、3倍重量の精製水を添加し、105℃付近に温度制御したマントルヒーターを用いて水蒸気蒸留を行った。蒸留は添加した精製水の半分量の留分が得られるまで行った。得られた蒸留及び蒸留残渣をそれぞれ常温にて1週間静置後、遠心及び濾過を行いチューリップエキスとした。
[製造例3]加熱還流
黄小町品種のチューリップ花部30g(新鮮重)を液体窒素中においてハンマーで粉砕し、2.4倍重量の精製水を添加し、オートクレーブを用いて105℃で6時間加熱した。その後、濾過し、得られた濾液を半分に分けた。濾液のみの濾過画分と、濾液残渣の半分量に濾液を加えた花部入り画分を調製し、それぞれに40%量(v/v)の1,3-ブチレングリコールを添加した。常温にて1週間静置後、それぞれ再濾過を行いチューリップエキスとした。
表1に示す4つの処方に基づいて4種の化粧水を作成し、スーパーオキシドアニオン消去能をSOD様活性率をして測定した。なお、試験濃度については検体を超純水によって連続希釈して計7濃度を調整し、試験を実施した。また、スーパーオキシドアニオン消去能の測定はSOD Assay Kit WST(Cat No.S311, Dojindo, Japan)を用いた。そして、ニコチンアミドモノヌクレオチドは株式会社アクセスワン社製を使用した。
評価方法について詳しくは、まず、96ウェルプレートに20μLの検体又は対照、200μLのWST working solution、及び20μLのEnzyme working solutionを加えた。また、ブランクにはEnzyme working solutionの代替としてDilution bufferを用いた。1つの処理軍に対して3ウェルを使用した。次に、プレートシールにより96ウェルプレートを密封し、270rpmで10秒間振とうし、37℃で20分間インキュベートした。次いで、マイクロプレートリーダーを用いて450nmの吸光度を測定した。そして、被験品、対照の吸光度から被験品のスーパーオキシドアニオン残存率及び消去率を次式により算出し、被験品のSOD様活性率とした。
[数1]スーパーオキシドアニオン残存率(%)
=(S-SB)/(C-CB)×100
[数2]スーパーオキシドアニオン消去率(%)
={(C-CB)-(S-SB)}/(C-CB)×100
=SOD様活性率(%)
C :対照の吸光度
CB:対照のブランク吸光度
S :被験品の吸光度
SB:被験品のブランク吸光度
Claims (3)
- チューリップの花部から抽出したチューリップエキスと、ニコチンアミドモノヌクレオチドを含有し、
前記チューリップエキスと、前記ニコチンアミドモノヌクレオチドを夫々外用剤全量に対し、0.0001重量%~1重量%含有することを特徴とする皮膚外用剤。 - 前記チューリップの品種が黄小町であり、前記チューリップエキスの抽出方法が加熱抽出又は常温抽出であることを特徴とする、請求項1記載の皮膚外用剤。
- 前記チューリップエキスの抽出溶媒が水、1,3-ブチレングリコール又はエタノールであることを特徴とする、請求項1又は2記載の皮膚外用剤。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022019778A JP7387951B2 (ja) | 2022-02-10 | 2022-02-10 | 皮膚外用剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022019778A JP7387951B2 (ja) | 2022-02-10 | 2022-02-10 | 皮膚外用剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023117200A JP2023117200A (ja) | 2023-08-23 |
JP7387951B2 true JP7387951B2 (ja) | 2023-11-29 |
Family
ID=87579751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022019778A Active JP7387951B2 (ja) | 2022-02-10 | 2022-02-10 | 皮膚外用剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7387951B2 (ja) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004261038A (ja) | 2003-02-28 | 2004-09-24 | Ishikawajima Harima Heavy Ind Co Ltd | 球根の輸送方法、栽培方法 |
JP2010207211A (ja) | 2009-02-12 | 2010-09-24 | Toyama Prefecture | α−メチレン−γ−ブチロラクトン類の製造方法 |
JP2019054485A (ja) | 2017-09-19 | 2019-04-04 | 日本電波工業株式会社 | パッケージ及び圧電デバイス |
JP2020054795A (ja) | 2019-06-13 | 2020-04-09 | 株式会社大都技研 | 遊技台 |
JP2021008447A (ja) | 2019-07-01 | 2021-01-28 | ベイジン サイエンスキュアキャンサー テクノロジー カンパニー リミテッド | 成年女性、高齢者及び亜健康状態の人々に適用できる健康保持製品組成物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02243613A (ja) * | 1989-03-16 | 1990-09-27 | Ichimaru Pharcos Co Ltd | アントシアニン系色素成分含有化粧料並びにアントシアニン系色素成分含有化粧料の退色防止法 |
JP3415200B2 (ja) * | 1993-06-30 | 2003-06-09 | 三省製薬株式会社 | 皮膚外用剤 |
US11219590B2 (en) * | 2017-09-14 | 2022-01-11 | Megumi Tanaka | Anti-aging agent and anti-aging method |
CN112739222A (zh) * | 2018-09-14 | 2021-04-30 | 田中惠 | 抗衰老剂以及抗衰老方法 |
-
2022
- 2022-02-10 JP JP2022019778A patent/JP7387951B2/ja active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004261038A (ja) | 2003-02-28 | 2004-09-24 | Ishikawajima Harima Heavy Ind Co Ltd | 球根の輸送方法、栽培方法 |
JP2010207211A (ja) | 2009-02-12 | 2010-09-24 | Toyama Prefecture | α−メチレン−γ−ブチロラクトン類の製造方法 |
JP2019054485A (ja) | 2017-09-19 | 2019-04-04 | 日本電波工業株式会社 | パッケージ及び圧電デバイス |
JP2020054795A (ja) | 2019-06-13 | 2020-04-09 | 株式会社大都技研 | 遊技台 |
JP2021008447A (ja) | 2019-07-01 | 2021-01-28 | ベイジン サイエンスキュアキャンサー テクノロジー カンパニー リミテッド | 成年女性、高齢者及び亜健康状態の人々に適用できる健康保持製品組成物 |
Non-Patent Citations (2)
Title |
---|
Detoxifying Cream,ID 771278,Mintel GNPD[online],2007年9月,[検索日2023.05.01],インターネット<https://www.portal.mintel.com> |
峯田 一隆 Kazutaka Mineda,コラーゲン特異的分子シャペロンHSP47誘導剤開発と化粧品への応用 Development of a new inducer of HSP47 and application to anti-aging cosmetics,フレグランスジャーナル 7月号 ,第37巻,p.89-91 |
Also Published As
Publication number | Publication date |
---|---|
JP2023117200A (ja) | 2023-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5969738B2 (ja) | 抗糖化作用剤 | |
WO2001055128A1 (de) | Benzofuranonderivate enthaltende formulierung zum schutz vor oxidativem stress | |
JP2003113068A (ja) | 皮膚化粧料 | |
JP4489923B2 (ja) | 皮膚外用剤 | |
JP2006257058A (ja) | リパーゼ阻害剤及びそれを配合した頭髪用剤及び皮膚外用剤。 | |
KR20110068949A (ko) | 매실나무 추출물 및 그 제조방법과 용도 | |
JP4866501B2 (ja) | 皮膚外用剤 | |
JP7387951B2 (ja) | 皮膚外用剤 | |
JP2006257060A (ja) | テストステロン5α−レダクターゼ阻害剤及びそれを配合した頭髪用剤及び皮膚外用剤。 | |
JP3809003B2 (ja) | 美白剤 | |
JP4063496B2 (ja) | 皮膚美白用組成物 | |
JP2013159603A (ja) | 皮膚美白作用を有するアントシアニン誘導体の製造方法 | |
JPS5948808B2 (ja) | 化粧料 | |
KR102366234B1 (ko) | 데스모디움 스컥스(Desmodium sequax Wall) 유래의 피부 주름 개선효과를 보이는 용매 추출물 또는 이의 분획물 | |
JP3647295B2 (ja) | 過酸化脂質生成抑制剤及びこれを含有する組成物 | |
JP3647296B2 (ja) | チロシナーゼ活性阻害およびこれを含有する組成物 | |
KR0180689B1 (ko) | 흑화 성분을 제거하여 개선된 미백효과를 갖는 반하 비극성 지질 분획 추출물 및 이를 함유하는 기미, 주근깨 개선 및 피부미백용 조성물 | |
JP5946698B2 (ja) | 美白剤及び皮膚化粧料 | |
KR101323781B1 (ko) | 대량강으로부터 추출한 항균 유효성분을 함유하는 항민감성 피부용 화장료조성물 | |
KR102553245B1 (ko) | 녹악매 추출물을 유효성분으로 포함하는, 항산화 또는 노화 억제용 조성물 | |
JP3597068B2 (ja) | 抗酸化剤及びこれを含有する組成物 | |
JP3628196B2 (ja) | 抗酸化剤及びこれを含有する組成物 | |
JP3317735B2 (ja) | 紅斑抑制・色素沈着抑制用皮膚化粧料 | |
JP3597067B2 (ja) | 抗酸化剤及びこれを含有する組成物 | |
JP4402274B2 (ja) | 皮膚外用剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20230405 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20230405 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230523 |
|
RD13 | Notification of appointment of power of sub attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7433 Effective date: 20230605 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230627 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230823 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230828 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20231010 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20231012 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20231012 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7387951 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |